Effect of Garcinia mangostana Linn Extract on Systolic Blood Pressure and Inflammation in Hypertensives: A Systematic Review and Meta-Analysis

Main Article Content

Arga S. Adji
Atiyatum Billah
Nadhifa N. Dhiyanisa
Nabella C. Nikmah
Kellyn T. Zenjaya
Wally W. Mukhammad
Bambang E. Suwito
Betty Roosihermiatie

Abstract

The potential of Garcinia mangostana Linn Extract (GMLE) in managing hypertension has garnered increased interest, although its effects are not yet fully understood. This meta-analysis aimed to evaluate the efficacy of the GMLE in reducing systolic blood pressure (SBP) and inflammation. A systematic search of PubMed, Google Scholar, and Science Direct was conducted in April 2024, including randomized controlled trials (RCTs) and cohort studies that compared the GMLE to a placebo. The analysis included 299 participants from three RCTs and one cohort study. The results indicated that, compared with the placebo, the GMLE significantly reduced SBP (SMD = -1.25, p = 0.003, I² = 69%). Additionally, GMLE was associated with significant decreases in inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP) (SMD = -5.09, p = 0.03), interleukin-1 (IL-1) (SMD = -1.04, p < 0.00001), and interleukin-6 (IL-6) (SMD = -1.05, p < 0.00001). In conclusion, GMLE appears to be an effective option for managing hypertension and may offer a safer, more economical alternative to conventional treatments. 

Downloads

Download data is not yet available.

Article Details

How to Cite
Adji, A. S., Billah, A., Dhiyanisa, N. N., Nikmah, N. C., Zenjaya, K. T., Mukhammad, W. W., Suwito, B. E., & Roosihermiatie, B. (2024). Effect of Garcinia mangostana Linn Extract on Systolic Blood Pressure and Inflammation in Hypertensives: A Systematic Review and Meta-Analysis . Tropical Journal of Natural Product Research (TJNPR), 8(12), 9377-9385. https://doi.org/10.26538/tjnpr/v8i12.5
Section
Articles

How to Cite

Adji, A. S., Billah, A., Dhiyanisa, N. N., Nikmah, N. C., Zenjaya, K. T., Mukhammad, W. W., Suwito, B. E., & Roosihermiatie, B. (2024). Effect of Garcinia mangostana Linn Extract on Systolic Blood Pressure and Inflammation in Hypertensives: A Systematic Review and Meta-Analysis . Tropical Journal of Natural Product Research (TJNPR), 8(12), 9377-9385. https://doi.org/10.26538/tjnpr/v8i12.5

References

John OD, Mouatt P, Panchal SK, Brown L. Rind from purple mangosteen (Garcinia mangostana) attenuates diet‐induced physiological and metabolic changes in obese rats. Nutrients. 2021;13(2) p.319-325.

Tousian Shandiz H, Razavi BM, Hosseinzadeh H. Review of Garcinia mangostana and its Xanthones in Metabolic Syndrome and Related Complications. Vol. 31, Phytotherapy Research. John Wiley and Sons Ltd; 2017. p. 1173–82.

Ismail AMZ, Sargowo D, Tjahjono CT, Widito S, Rizal A, Rahimah AF. The Role of Garcinia mangostana Pericarp Extract as Antioxidant to Inhibit Atherosclerosis Process in High-Risk Framingham Score Patient. Heart Science Journal. 2021;2(1) p.25-29.

Fadlan MR, Rizal A, Sargowo D. 12 Garcinia mangostana Linn Extract Reduces Systolic Blood Pressure And Inflamation Process In Patient’s With Hypertension. J Hypertens. 2019;37 p 1-3.

Elmund B, Hartrianti P. Evaluation of mangosteen (Garcinia Mangostana) antioxidant activity in clinical trials and in vivo animal studies: A systematic review. J Appl Pharm Sci. 2020 Jan 1;10(12):114–29.

Xu Y, Wu J, Gao L, Lin H, Yang Z, Liu X, Niu Y. α-Mangostin reduces hypertension in spontaneously hypertensive rats and inhibits EMT and fibrosis in Ang II-induced HK-2 cells. Int J Med Sci. 2024; 21(9):1681–8.

John OD, Mushunje AT, Surugau N, Guad R Mac. The metabolic and molecular mechanisms of αmangostin in cardiometabolic disorders (Review). Int J Mol Med. 2022;50(3).

Soetikno V, Murwantara A, Andini P, Charlie F, Lazarus G, Louisa M. Alpha-mangostin improves cardiac hypertrophy and fibrosis and associated biochemical parameters in high-fat/high-glucose diet and low-dose streptozotocin injection-induced type 2 diabetic rats. J Exp Pharmacol. 2020;12:27–38.

Kwaifa IK, Bahari H, Yong YK, Md Noor S. Endothelial dysfunction in obesity-induced inflammation: Molecular mechanisms and clinical implications. Vol. 10, Biomolecules. 2020 p.291.

Handayani O, Sargowo D, Rohman MS, Satrijo B, Tjahjono CT, Hendrawan D. The Effect of Add-on Garcinia mangostana L. Extract on Endothelial Dysfunction in Type 2 Diabetes Mellitus Subjects with High Risk Framingham Score: A Cohort Study. Heart Science Journal. 2020;1(1) p.21-25.

John OD, Brown L, Panchal SK. Garcinia Fruits: Their Potential to Combat Metabolic Syndrome. In: Nutraceuticals and Natural Product Derivatives. 2019. p. 39–71.

Textor SC, Schwartz GL, Frye RL. The new hypertension guidelines from JNC 7: Is the devil in the details? Vol. 78, Mayo Clinic Proceedings. 2003 p.1078.

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Vol. 16, Nature Reviews Nephrology. 2020; 16 (4) p.223-237.

Chobanian A V., Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Vol. 42, Hypertension. 2003 p.1206-1210.

Tinawi M. New Trends in the Diagnosis and Management of Hypertension. Cureus. 2022;14 (2), p.221-230

Kowalski S, Goniewicz K, Moskal A, Al-Wathinani AM, Goniewicz M. Symptoms in Hypertensive Patients Presented to the Emergency Medical Service: A Comprehensive Retrospective Analysis in Clinical Settings. J Clin Med. 2023;12(17).

Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6).

Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304).

Boateng EB, Ampofo AG. A glimpse into the future: modeling global prevalence of hypertension. BMC Public Health. 2023;23(1).

Akram M, Rashid A, Talha Khalil M, Anwar H, Siddique A, Shahid N, Kiraz AO, Laila U, Zainb R, Solowski G. Herbal Treatment of Hypertension: Literature Review. Journal of Biochemicals and Phytomedicine. 2023;2(1).

Saraswathy SUP, Lalitha LCP, Rahim S, Gopinath C, Haleema S, SarojiniAmma S, Aboul-Enein HY. A Review on Synthetic and Pharmacological Potential of Compounds Isolated from Garcinia mangostana Linn. Vol. 2, Phytomedicine Plus. Elsevier B.V.; 2022 p.1-17.

Abdalrahim F. A. Aisha,. Quantification of α-, β- and γ-mangostin in Garcinia mangostana fruit rind extracts by a reversed-phase high-performance liquid chromatography. Journal of Medicinal Plants Research. 2012 Aug 1;6(29).

Mahmudah R, Sukandar EY, Adnyana IK. In-silico and In vivo Long-term Safety Studies of Mangosteen Rind Ethanol Extract (Garcinia mangostana Linn.). Tropical Journal of Natural Product Research. 2024 Feb 1;8(1):5980–6.

Anam, K., Munandar, R., Wulandari, O. N., Lestari, A. B., Farada, R. E., Hudiyanti, D., & Aminin, A. L. (2023). Chemical Composition, Antioxidant Activities, and Total Phenolic Content of Combination of Mangosteen (Garcinia mangostana L.) Peel-Kodavan (Centella asiatica L. Urban) Fractions: http://www.doi.org/10.26538/tjnpr/v7i1.20. Tropical Journal of Natural Product Research (TJNPR), 7(1), 2222-2228.

Setiawan AA, Budiman J, Prasetyo A. Anti-Inflammatory Potency of Mangosteen (Garcinia mangostana L.): A Systematic Review. Open Access Maced J Med Sci. 2023 Jan 2;11(F):58–66.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Wilson EM, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Vol. 372, The BMJ. BMJ Publishing Group; 2021.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. RoB 2: A revised tool for assessing risk of bias in randomized trials. The BMJ. 2019;366.

Fadlan MR, Fadlan MR, Sargowo D, Rizal A. A17631 Effectivity of Garcinia mangostana Linn extract to Reduce Blood Pressure and Inflammatory process in Hypertension Patient with High Risk Framingham Score’s. J Hypertens [Internet]. 2018 Oct [cited 2024 Apr 7];36:e226. Available from: https://doi.org/10.1097/01.hjh.0000548923.33085.c0

Boonprom P, Boonla O, Chayaburakul K, Welbat JU, Pannangpetch P, Kukongviriyapan U, Kukongviriyapan V, Pakdeechote P, Prachaney P. Garcinia mangostana pericarp extract protects against oxidative stress and cardiovascular remodeling via suppression of p47phox and iNOS in nitric oxide deficient rats. Ann Anat [Internet]. 2017 Jul 1 [cited 2024 Apr 7];212:27–36. Available from: https://doi.org/10.1016/j.aanat.2017.03.007

Abdallah HM, El-Bassossy HM, Mohamed GA, El-halawany AM, Alshali KZ, Banjar ZM. Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation. BMC Complement Altern Med [Internet]. 2016 Sep 13 [cited 2024 Apr 7];16(1). Available from: https://doi.org/10.1186/s12906-016-1340-5

Ismail AMZ, Sargowo D, Tjahjono CT, Widito S, Rizal A, Rahimah AF. The Role of Garcinia mangostana Pericarp Extract as Antioxidant to Inhibit Atherosclerosis Process in High Risk Framingham Score Patient; Original Article. Heart Science Journal [Internet]. 2021 [cited 2024 Apr 7];2(1):25–9. Available from: https://doi.org/10.21776/UB.HSJ.2021.002.01.04

Sargowo D. A15951 The Role of Garcinia mangostana L Extract as Anti-inflammatory, Anti-diabetic, and Anti-cholesterol in High Risk Cardiovascular Patient. J Hypertens [Internet]. 2018 Oct [cited 2024 Apr 7];36:e237. Available from: https://doi.org/10.1097/01.hjh.0000548969.61794.43

Mohan S, Syam S, Abdelwahab SI, Thangavel N. An anti-inflammatory molecular mechanism of action of α-mangostin, the major xanthone from the pericarp of Garcinia mangostana: an in silico, in vitro and in vivo approach. Food Funct. 2018 Jul 1;9(7):3860–71.

Ovalle-Magallanes B, Eugenio-Pérez D, Pedraza-Chaverri J. Medicinal properties of mangosteen (Garcinia mangostana L.): A comprehensive update. Vol. 109, Food and Chemical Toxicology. Elsevier Ltd; 2017. p. 102–22.

Adji AS, de Liyis BG. Comparison between nonvitamin K oral antagonist versus warfarin in atrial fibrillation with and without valvular heart disease: a systematic review and meta-analysis. Vol. 76, Egyptian Heart Journal. Springer Science and Business Media Deutschland GmbH; 2024, 80 (3)

Adji AS, Billah A, Baraja A, Putri AAP, Rahman FS. A Systematic Review and Meta-analysis of Randomized Placebo-controlled Trials 1 Year after Starting Sodium-glucose Transporter-2 Inhibitors in Heart Failure Patients with Reduced Ventricular Ejection Fraction. Vol. 10, Open Access Macedonian Journal of Medical Sciences. Scientific Foundation SPIROSKI; 2022. p. 1–6.

Li KX, Wang ZC, Machuki JO, Li MZ, Wu YJ, Niu MK, Yu KY, Lu QB, Sun HJ. Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension? Vol. 13, Frontiers in Materials. Frontiers Media S.A.; 2022, 1(13) p.221-228

Li J, Zeng X, Yang F, Wang L, Luo X, Liu R, Zeng F, Lu S, Huang X, Lei Y, Lan Y. Resveratrol: Potential Application in Sepsis. Vol. 13, Frontiers in Pharmacology. Frontiers Media S.A.; 2022, p 4-15.

Adji AS, Atika N, Kusbijantoro YB, Billah A, Putri A, Handajani F. A review of Leaves and Seeds Moringa oleifera Extract: The potential Moringa oleifera as Antibacterial, Anti-Inflammatory, Antidiarrheal, And Antiulcer Approaches To Bacterial Gastroenteritis. Open Access Maced J Med Sci. 2022 Apr 20;10(F):305–13.

Adji AS, Widjaja JS, de Liyis BG. Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis. Vol. 76, Egyptian Heart Journal. Springer Science and Business Media Deutschland GmbH; 2024

Suwito BE, Adji AS, Wardani VAK, Widjaja JS, Angel SCS, Rahman FS. A review of CRISPR Cas9 for ASCVD: treatment strategies and could target PSCK9 gene using CRISPR cas9 prevent the patient from atherosclerotic vascular disease? Vol. 11, Bali Medical Journal. Sanglah General Hospital; 2022. p. 985–93.

Perdana EY, Miranti IP, Kholis FN, Wijayahadi N, Setiawan AA. Effects of Garcinia mangostana Linn Pericarp Extract and Physical Exercise on Atheroembolic Histopathologic Features Kidney in Wistar Rats with Metabolic Syndrome. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). 2024;13(2):83–91.